BB Alzheimer’s Disease Assessment
$499.00
Item number:
BB-ALZHEIMERS-TAU
Tau–Amyloid Profiling for Cognitive Insight
This panel evaluates Alzheimer’s disease related brain changes using FDA-cleared blood-based biomarkers:
- Lumipulse® pTau217 / Aβ1-42 Plasma Ratio
- Phosphorylated Tau-217 (pTau217)
- Indicates neuronal injury and tau pathology
- β-Amyloid 1-42 (Aβ1-42)
- Reflects amyloid plaque accumulation in the brain
Want help interpreting your results? ExtendingMe Educators are available. Book a 30-minute one-on-one coaching session and receive personalized guidance tailored to your panel. (Applies to one panel per session.)